Ad
ASMB Quote Trading Chart Assembly Biosciences Inc.
home / stock / asmb / asmb quote
Quote | Assembly Biosciences Inc. (NASDAQ:ASMB)
| Last: | $15.07 |
|---|---|
| Change Percent: | 1.24% |
| Open: | $15.91 |
| Close: | $15.07 |
| High: | $15.91 |
| Low: | $14.75 |
| Volume: | 42,283 |
| Last Trade Date Time: | 12/11/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
ASMB Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $15.07 | $15.91 | $15.07 | $15.91 | $14.75 | 42,283 | 12-11-2024 |
| $16.11 | $16.04 | $16.11 | $16.66 | $15.8 | 42,259 | 12-10-2024 |
| $16.695 | $16.05 | $16.695 | $16.98 | $16.05 | 27,782 | 12-09-2024 |
| $16.05 | $16.47 | $16.05 | $16.47 | $16 | 11,474 | 12-06-2024 |
| $16.32 | $16.23 | $16.32 | $16.48 | $16.13 | 14,332 | 12-05-2024 |
| $16.31 | $16.5 | $16.31 | $16.66 | $15.96 | 28,848 | 12-04-2024 |
| $16.4 | $16.61 | $16.4 | $16.99 | $15.57 | 95,396 | 12-03-2024 |
| $16.75 | $17.38 | $16.75 | $17.4 | $16.5101 | 22,881 | 12-02-2024 |
| $17.04 | $16.8 | $17.04 | $17.28 | $16.78 | 23,048 | 11-29-2024 |
| $16.83 | $15.35 | $16.83 | $16.83 | $15.35 | 89,387 | 11-28-2024 |
| $16.83 | $15.35 | $16.83 | $16.83 | $15.35 | 89,387 | 11-27-2024 |
| $15.2 | $15.14 | $15.2 | $15.666 | $14.8 | 39,398 | 11-26-2024 |
| $14.81 | $15 | $14.81 | $15.5999 | $14.69 | 42,421 | 11-25-2024 |
| $15.04 | $14.75 | $15.04 | $15.2 | $14.45 | 28,353 | 11-22-2024 |
| $14.72 | $13.41 | $14.72 | $15.36 | $13.41 | 63,870 | 11-21-2024 |
| $15.02 | $15.34 | $15.02 | $15.34 | $14.6 | 19,216 | 11-20-2024 |
| $15.34 | $15.94 | $15.34 | $16.412 | $15.23 | 11,982 | 11-19-2024 |
| $15.84 | $16.29 | $15.84 | $16.44 | $15.55 | 32,342 | 11-18-2024 |
| $16.14 | $16.86 | $16.14 | $17.035 | $16 | 17,919 | 11-15-2024 |
| $17.05 | $16.85 | $17.05 | $17.48 | $16.4 | 32,217 | 11-14-2024 |
News, Short Squeeze, Breakout and More Instantly...
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
Ad
-
2024-11-27 15:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
2024-11-17 00:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Positive Phase 1a interim data released for ABI-5366, a long-acting HSV helicase-primase inhibitor candidate for recurrent genital herpes, supporting potential for once-weekly and once-monthly oral dosing First participants dosed in Phase 1b trial evaluating ABI-5366 in individuals with r...